Working to Eradicate Gynecologic Cancers

Education Forum VI: Tumor Board

Monday, March 24, 2014: 5:00 PM-6:15 PM
Ballroom B/C (Tampa Convention Center)
Description: This Tumor Board will cover the current and up to date for Optimal Surgical Resection vs. neoadjuvant chemotherapy. Course faculty will present a patient with advanced disease to discuss who is a candidate for neoadjuvant chemotherapy and how to evaluate. The second part of the case will center around the optimal chemotherapy for this patient. This will include the use of dose dense chemotherapy and anti-vascular agents. Pre- and post- discussion questions will be asked from the audience.
Faculty:  Alpa M. Nick, MD1, John K. Chan, MD2 and Robert L. Coleman, MD1, (1)The University of Texas MD Anderson Cancer Center, Houston, TX(2)UCSF Helen Diller Comprehensive Cancer Center, San Francisco, CA
Course Directors:  R. Wendel Naumann, MD, Carolinas Medical Center, Charlotte, NC
5:00 PM
Introduction
R. W. Naumann
Levine Cancer Institute, Charlotte, NC
 
5:01 PM
Faculty
R. L. Coleman
The University of Texas MD Anderson Cancer Center, Houston, TX
 
5:21 PM
Faculty
J. K. Chan
UCSF Helen Diller Comprehensive Cancer Center, San Francisco, CA
 
5:41 PM
Faculty
A. M. Nick
The University of Texas MD Anderson Cancer Center, Houston, TX
 
6:01 PM
Panel Discussion
 
See more of: Education Forum
<< Previous Course | Next Course >>